Company created to progress experimental Alzheimer's disease therapy
Company created to progress experimental Alzheimer's disease therapy
| The group has previously shown that molecules that act on RAR-alpha can affect multiple parts of the Alzheimer's
disease pathway and therefore have the potential to produce an
effective therapy that would otherwise need several points of
intervention ... |  |